Abstract
efficient execution of cell death signalling is the desirable fate of cancer chemotherapy, and therefore the need to identify novel compounds with better apoptotic potential. Over the years, our laboratory has been studying the mechanism(s) underlying resistance to death signalling in tumour cell with the ultimate goal of identifying druggable targets for enhancing the efficacy of cancer chemotherapy.
Original language | English |
---|---|
Pages (from-to) | 144 |
Number of pages | 1 |
Journal | European Journal of Cancer. Supplement |
Volume | 4 |
Issue number | 12 |
DOIs | |
Publication status | Published - Nov 2006 |